Genetic biomarkers could personalise therapy for TNBC
Drug Discovery World
AUGUST 16, 2023
A new study has shed light on the genetic messages encoded by genes within ‘triple negative’ breast cancers (TNBC), and shows they could predict response to chemotherapy. “Our findings paint a complex picture – with many, dynamic factors driving how tumours respond to treatment.”
Let's personalize your content